The Most Discounted New Cars And SUVs You Can Buy In April 2025, According To Consumer Reports
Considering the current state of the economy and the risk all these Republican tariffs and uncertainty pose to employment, this isn't exactly what we'd call an ideal time to buy a new car. And yet, plenty of people find themselves in a position where buying now might still be a better option than putting it off and potentially paying more in the future when their car finally dies for good. Used cars tend to be cheaper, but on the other hand, there's less risk over the next several years if you buy new.
If you're one of those potential buyers, then how do you get a good deal on a new car? Well, one of the best ways is to find a car that's already heavily discounted. Those aren't necessarily going to be the coolest, most in-demand vehicles, but they do all come with a warranty. So which new cars currently have the biggest discounts? Our friends at Consumer Reports recently sorted through actual transaction data from TrueCar to figure that out, and while the actual discounts at your local dealer may differ, including between trim levels, this list is at least a good place to begin your search.
Read more: Consumer Reports' 10 Best Used Cars Under $20,000 Are A Great Way To Dodge Republican Tariffs
2025 Subaru Legacy Premium AWD
Consumer Reports' Overall Score: 82
MSRP: $27,510
Average Transaction Price: $26,187
Average Discount: $1,323
2025 Audi A3 Premium Plus 40 TFSI quattro
Consumer Reports' Overall Score: 76
MSRP: $38,200
Average Transaction Price: $36,362
Average Discount: $1,838
2025 Infiniti QX50 Luxe AWD
Consumer Reports' Overall Score: 69
MSRP: $46,300
Average Transaction Price: $43,865
Average Discount: $2,435
2025 Subaru Outback Touring XT AWD
Consumer Reports' Overall Score: 85
MSRP: $42,910
Average Transaction Price: $40,638
Average Discount: $2,272
2025 Mercedes-Benz C 300
Consumer Reports' Overall Score: 65
MSRP: $48,450
Average Transaction Price: $45,556
Average Discount: $2,894
2025 Mercedes-Benz GLB250
Consumer Reports' Overall Score: 58
MSRP: $45,800
Average Transaction Price: $42,913
Average Discount: $2,887
2025 BMW i4 eDrive35 Gran Coupe
Consumer Reports' Overall Score: 89
MSRP: $52,800
Average Transaction Price: $49,416
Average Discount: $3,384
2025 Mercedes-Benz EQB250+
Consumer Reports' Overall Score: N/A
MSRP: $53,050
Average Transaction Price: $49,526
Average Discount: $3,524
2025 Mercedes-Benz GLA250 4Matic
Consumer Reports' Overall Score: 55
MSRP: $45,000
Average Transaction Price: $41,905
Average Discount: $3,095
2025 Mercedes-Benz CLA250
Consumer Reports' Overall Score: 59
MSRP: $44,400
Average Transaction Price: $39,826
Average Discount: $4,574
Want more like this? Join the Jalopnik newsletter to get the latest auto news sent straight to your inbox...
Read the original article on Jalopnik.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
State Street water main break could cause traffic delays lasting 12 hours, police warn
SALT LAKE CITY () — Northbound traffic on State Street in Salt Lake City could see delays over the next 12 hours, according to the Salt Lake City Police Department, due to a break in a water main. Salt Lake police announced the closure at 12:30 p.m. on Tuesday, June 9. To allow for crews to investigate and repair the break, the northbound lanes have been closed from Kensington Avenue to 1300 South. Officials hope to have one lane open by 1:30 p.m. Photos shared from the scene show the roadway suffered extensive damage from the apparent water main break. The asphalt can be seen buckling, separating from the curb, and sending a large crack and dip through the road's shoulder into the right-most lane. The Salt Lake City Police Department said early estimates suggest the northbound traffic on State Street in the area could be down to one lane for about 12 hours while crews repair the main. House Oversight Republicans schedule interviews with former Biden aides New monitoring plan announced to learn more about Great Salt Lake dust, inform public More sexual assault charges filed against Provo OBGYN David Broadbent Senate Republican calls July 4 'false deadline' for megabill Several Park City businesses evacuated due to gas leak near Main Street Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
an hour ago
- Yahoo
Factbox-Los Angeles, progressive beacon at center of anti-Trump backlash
By Costas Pitas LOS ANGELES (Reuters) -Protests in Los Angeles against raids on suspected undocumented immigrants have turned into the strongest domestic backlash against President Donald Trump since he took office in January. Here is how the Democratic-leaning city and state of California vary from Trump's Republicans and his support in the U.S. heartland. PARTY POLITICS Nationwide, Trump won around 2.5 million more votes than his Democratic rival Kamala Harris in the November presidential election but in Los Angeles, Harris won by a margin of roughly two to one. Of the 50 U.S. states, California backed Harris by the fifth largest margin. California is also home to several top-level Democrats, including Harris herself, and long-time former Speaker of the House of Representatives Nancy Pelosi. Governor Gavin Newsom is a Democrat, as is the mayor of Los Angeles, Karen Bass. Both have complained about Trump's tactics this week. The party raises millions in the state from wealthy donors and grassroots supporters, sometimes in a single day. DEMOGRAPHICS At 27.3%, California has the highest foreign-born population of any U.S. state, compared to 13.9% of the total U.S. population, according to a 2024 Census report. Nearly half of Angelenos are Hispanic or Latino and some 35% of the city's total population is foreign-born, according to the American Community Survey, with many cultural and business ties to Mexico, which is only about a two-hour drive south. ENVIRONMENTAL REGULATIONS Faced with persistently bad air quality, especially in cities with strong driving cultures such as Los Angeles, California has developed some of the strictest environmental regulations in the country, opposed by many Republicans. A landmark plan to end the sale of gasoline-only vehicles by 2035 in California is in the crosshairs of a battle between its Democratic leadership and the Republican-run federal government, also because many other states replicate California's first-in-the-nation action. In May, the Republican-run Senate in Washington voted to ban the plan and it is now awaiting Trump's signature. He is expected to sign it this week, according to industry officials. HOLLYWOOD American movies and television are one of the most visible U.S. exports, emanating from an LA-based industry that had been hailed by liberals for boosting diversity but criticized by some conservatives for creating films that include LGBT stories. In May, Trump suggested a tariff on movies produced in foreign countries to protect a domestic industry that he said was "dying a very fast death." But when China retaliated by saying it would curb American film imports, he prompted laughter at a cabinet meeting by a response that signaled his derision for Hollywood: "I think I've heard of worse things."
Yahoo
an hour ago
- Yahoo
Opinion - Trump shouldn't import socialist price controls
Remember when Republican presidential candidate Donald Trump castigated 'Comrade Kamala' Harris, then the Democratic nominee, for supporting price controls? It wasn't that long ago — just last August. At a campaign rally in Pennsylvania, Trump told the crowd: 'In her speech yesterday, Kamala went full Communist … She wants to destroy our country. After causing catastrophic inflation, Comrade Kamala announced that she wants to institute socialist price controls.' Harris's price controls were largely aimed at food in grocery stores, though she also frequently touted the 2022 Inflation Reduction Act's backdoor price controls — under the guise of 'negotiations' — on a certain number of expensive drugs. Trump was right to criticize Harris for supporting price controls on food, as well as prescription drugs. And, given the election results, it seems the public agreed with him. Price controls are the progressive left's go-to solution for almost all economic problems. But price controls virtually always lead to unintended consequences: shortages of the price-controlled products or services; lower quality as manufacturers cut corners to meet government-imposed price points; less innovation, since companies don't know if they'll be allowed to recover their costs; and a black market where people pay more to get what they want or need. So it's puzzling to see Trump now proposing a version of drug price controls himself. It's not the first time, either. During his first term, Trump pushed for 'drug importation,' encouraging U.S. citizens to buy medicines from countries like Canada — even though the FDA has warned those drugs could be fake or substandard. The effort fizzled, and even Florida, which tried a state-level importation scheme, eventually abandoned its program. Trump's latest idea is called 'Most Favored Nation' pricing. Details are thin, but a recent executive order says, 'To the extent consistent with law, the Secretary of Health and Human Services (Secretary) shall facilitate direct-to-consumer purchasing programs for pharmaceutical manufacturers that sell their products to American patients at the most-favored-nation price.' That 'most-favored' country will almost certainly be one with government-run health care — that is, socialized medicine. These systems are known for price controls, which lead to shortages, long wait times, and limited access to cutting-edge treatments. The goal of Most Favored Nation is to lower prices on expensive drugs. Americans do pay more for brand-name drugs than patients elsewhere. But they also pay less for generics, which account for roughly 90 percent of all prescriptions. One reason for the disparity is the middlemen in our system, known as pharmacy benefit managers. Their job is to negotiate lower prices with drugmakers. But those savings often don't make it to patients. Instead, pharmacy benefit managers keep a big chunk for themselves — on average, $0.42 of every $1 spent on brand-name drugs in the commercial market, by one estimate. In many cases, those pharmacy benefit manager cuts are larger than the total price of the drug in Europe. It's clear our system could work better. 'Shark Tank' entrepreneur Mark Cuban launched the Cost Plus Drug Company in 2022 to bypass these middlemen. The Cost Plus website says, 'Our prices are the true cost to get each medication from the manufacturer to you. We cut out the pharmacy middlemen and negotiate directly with manufacturers to get the best possible price.' The company tacks on 15 percent for overhead and a $5 filling fee. While customers may not save much on some widely used generics, the discounted prices on more expensive brand name and generic drugs are significantly lower than what most people would experience at their local pharmacy. Cost Plus has hundreds of drugs for nearly 100 listed medical conditions, and it's looking to add new drugs all the time. It's only been in business a few years and is working to expand. We also shouldn't ignore the fact that Americans are subsidizing below-market prices abroad. The United States funds a disproportionate share of global pharmaceutical innovation, while other wealthy nations impose price caps and benefit from our investment. If Trump wants to stop other countries from taking advantage of us, he should take the approach he's using to get countries to pay more for defense. Cuban's Cost Plus experiment proves we don't need Most Favored Nation pricing. Let socialized systems keep their socialized prices, limited access and denial of care. Tweaking a line Trump likes to use and applying it to prescription drugs: We don't need a new law. We just don't need a middleman. Merrill Matthews is a public policy and political analyst and the co-author of 'On the Edge: America Faces the Entitlements Cliff.' Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
